1. Home
  2. Analysis
  3. Dacarbazine
  4. Velcade

Dacarbazine and Velcade drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dacarbazine (dacarbazine) and Velcade (bortezomib). Common drug interactions include contusion among females and dermatitis exfoliative generalised among males.

The phase IV clinical study analyzes what interactions people have when they take Dacarbazine and Velcade. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Dacarbazine?

Dacarbazine has active ingredients of dacarbazine. eHealthMe is studying from 8,064 Dacarbazine users. Check the latest studies of Dacarbazine.

What is Velcade?

Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 66,422 Velcade users. Check the latest studies of Velcade.

On Jul, 15, 2026

23 people who take Dacarbazine and Velcade together, and have interactions are studied.

Dacarbazine and Velcade drug interactions.

What are the common drug interactions of Dacarbazine and Velcade, by gender? *:

female:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Depression
  4. Disability
  5. Dizziness
  6. Ear infection
  7. Excoriation (to tear or wear off the skin of)
  8. Fall
  9. Hyperglycaemia (high blood sugar)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

male:

  1. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  2. Death
  3. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  4. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)

What are the common drug interactions of Dacarbazine and Velcade, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Dizziness
  4. Ear infection
  5. Excoriation (to tear or wear off the skin of)
  6. Fall
  7. Hyperglycaemia (high blood sugar)
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Injury
  10. Oral disorder (mouth disease)

What are the existing conditions these people have? *

  1. Nausea And Vomiting: 3 people, 13.04%
  2. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 13.04%
  3. Malignant Melanoma (skin cancer rises from melancytes): 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Dacarbazine and Velcade?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dacarbazine and Velcade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dacarbazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Velcade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dacarbazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Velcade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dacarbazine and bortezomib (the active ingredients of Dacarbazine and Velcade, respectively), and Dacarbazine and Velcade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.